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Abstract
Objective: RGS9 is a member of the family of Regulators of G-Protein Signaling (RGS) proteins defined by the
presence of an RGS domain which can accelerate the GTPase-activity of G protein Gα subunits. An insertion/deletion
(I/D) polymorphism of the nucleotide sequence TTTCT (rs3215227) has been identified in the human RGS9 gene,
which matches the consensus high affinity binding motif for the ubiquitously expressed RNA binding Polypyrimidine
Tract Binding Protein (PTB). In this study, we evaluate the genetic association and functional relevance of this
polymorphism in type 2 diabetes and obesity.
Subjects and methods: We genotyped a larger population of 9272 Chinese and Malaysian individuals for
the RGS9 I/D polymorphism using TaqMan allelic discrimination protocols. We found that the D allele of the RGS9
polymorphism was associated with a decreased prevalence of obesity in women (P=0.003, OR=0.753 95%CI
0.625-0.906) and girls (P=0.002, OR=0.604 95%CI 0.437-0.835). The association was moderate in boys (P=0.038,
OR=0.724 95%CI 0.533-0.983) and not significant in men. Furthermore, we found that the transcript deletion variant
exhibited a 10-fold reduction in PTB binding in vitro and that the splicing of the deletion variant was less affected by
PTB co-expression.
Conclusions: We provide genetic and biochemical data to support a genetic role of RGS9 in obesity but unlikely
in T2D. The RGS9 I/D polymorphism influence the post-transcriptional processing of the gene through an altered
affinity for the splicing factor PTB and are associated with obesity.

Keywords: Association; Obesity; Polypyrimidine tract binding

in obesity which could be produced either by heightening reward
responses to food or by suppressing energy expenditure [10-12].

Abbreviations: BMI: Body Mass Index; PTB: Polypyrimidine Tract

An Insertion/Deletion (I/D) polymorphism of the nucleotide
sequence TTTCT (rs3215227 in dbSNP) [13] has been identified
in intron 13 of the human RGS9 gene, which precisely matches the

protein; Regulators of G-protein signaling protein; Type 2 diabetes

Binding Protein; RGS9: Regulators of G-Protein Signaling Protein;
T2D: Type 2 Diabetes

Introduction
In the past decade, the prevalence of obesity and Type 2 Diabetes
Mellitus (T2D) is increasing worldwide particularly in the developing
countries undergoing economic transition to a market economy such
as China. A 1% increase in the prevalence of obesity in the country
leads to 20 million additional obese cases. The increase in obesity has
an important impact on the global incidence of T2D, cardiovascular
disease, cancer and other diseases [1-4]. Therefore, identification of the
genes and gene variations that regulate Body Mass Index (BMI) will
help us to understand the underlying mechanisms of the diseases and
possibly aid in the development of novel prevention and therapeutic
approaches.
RGS9 protein is a member of the family of Regulators of G-Protein
Signaling (RGS) proteins and expression of RGS9 is highly enriched
in the striatum region of the brain [5-9]. Dopaminergic circuits in the
striatum are activated by stimuli associated with reward and are also
densely interconnected with the hypothalamus, a brain region that
is critical for regulating energy expenditure [10]. These dopaminesensitive striatal reward centers have been shown to be involved
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consensus high affinity binding motif for the ubiquitously expressed
RNA binding Polypyrimidine Tract Binding Protein (PTB) [14]. PTB
and its neuronally expressed paralog nPTB [15] are the dominant
splicing repressor in humans and have been shown to regulate many
alternative splicing events. PTB and nPTB have indistinguishable
binding specificities and a near complete overlap of functional targets
[15]. PTB has also been implicated in polyadenylation, message
stabilization, translation from internal ribosome entry sites and as
a RNA chaperone [16]. The location of the RGS9 I/D polymorphism
[8] and coincidence with a PTB binding motif [14] suggested that the
presence of the deletion could alter processing of the RGS9 transcripts
and have important functional consequences: exons 13 and 14, that
flank the TTTCT I/D polymorphism, code for the conserved RGS
domain that mediates GTPase accelerating protein (GAP) function
[8,17]. Hence, incorrect splicing of these exons will result in protein
products that lack a functional RGS domain.
In a previous study, we demonstrated that rgs9 knockout mice
became obese and had increased adiposity compared to their wild-type
littermates [18]. Conversely, the virally transduced overexpression,
specifically of rgs9 proteins (and not other R7 RGS proteins) in the
nucleus accumbens (NAc) of rats produced a reduction in body weight
[18]. In that study, we also investigated if there was an association
between the RGS9 I/D polymorphism and BMI [18]. Since the microdeletion allele is rare in European Caucasians [13], we had genotyped
for the RGS9 I/D polymorphism in a limited number samples from
491 Asian individuals that was available to us [18] and found that the
mean BMI of individuals carrying with the D allele was significantly
higher than those that tested negative for the deletion. However, the
generalizability of those results was limited by 1) the limited sample
size, 2) the heterogeneous ethnic composition of the cohort which
included individuals who identified themselves as either Chinese,
Japanese, Korean, Pacific Islander, or Southeast Asian and 3) the
significant variation in the frequency of the D and I alleles between the
different ethnic groups.
To address these concerns, in this study, we asked if the I/D
polymorphism was associated with obesity in a larger sample of
2737 Chinese adults and 816 children. We also investigated whether
the polymorphism was associated with T2D in a sample of 6535
Chinese and Malaysian. Furthermore, we have expanded on those
results by demonstrating allelic differences in the binding of PTB to
the RGS9 transcript and present data from minigene experiments that
demonstrated allelic, PTB-dependent, effects on the splicing of RGS9
transcripts in vivo.

Sample

Origin

Region/Country

Sample 1

Chinese

Jiangsu, China

Sample 2

Chinese

Jiangsu, China

Sample 3

Chinese

Jiangsu, China

Sample 4

Chinese

Beijing, China

Sample 5

Malaysian

Penisular, Malaysia

Total

Group

Materials and Methods
Subjects
In the present study, a total of 9272 subjects in Chinese and
Malaysian populations were selected for genetic association study.
Clinical characteristics of the subjects are represented in Table 1.
Collection of the subjects in each cohort is described briefly as below.
First cohort: Lean and obese Chinese adults: A total of 4138
subjects were recruited in Jiangsu province, China, from a population
of 16,034 by epidemiological stratification sampling with ages ranging
from 35 to 85 years. According to the criteria of overweight/obesity for
Chinese from working group on obesity in China (WGOC) [19], 820
(females 541/ males 279) subjects with BMI>28 kg/m2 were defined as
having an obese phenotype and 1,100 (females 687/males 413) subjects
with BMI ranging from 18.5-23.9 kg/m2 were defined as having a lean
phenotype.
Second cohort: Chinese children with and without over-weight:
Chinese children aged 5-15 years were selected from primary and
middle schools located in Jiangsu province, China. The children and
their parents provided informed consent and completed a questionnaire
to provide information covering age, gender and education. Within this
population (n=2,373), 361 (157/204) children were overweight, i.e. had
a BMI that exceeded the 80th percentile for their age (P80) and 451
(215/236) children had BMIs that ranged from 20th to 50th percentile
(P20-50) for their age.
Third and fourth cohorts: Chinese adults with and without type
2 diabetes (T2D): Chinese adults with and without T2D were selected
respectively from the regions of Jiangsu province and Beijing city in
China. All patients with T2D were diagnosed according to the World
Health Organization (WHO) criteria, 1998 [20]. 1279 patients with
T2D and 1990 subjects with normal fasting plasma glucose levels were
included in the present study from Jiangsu province. 1049 (496/553)
patients with T2D and 1004 (520/484) non-diabetic subjects were
enrolled as previously described from regions around Beijing. Subjects
with BMI>28.0 kg/m2 were excluded from the study [21].
Fifth cohort: Adults with and without T2D from Malaysia:
Malaysians subjects including 575 (268/307) non-diabetic controls and
643 (311/332) T2D patients were collected from the university hospitals
in the states of Kelantan, Putrajaya and Penang, Malaysia. The ethnic
break-up of the Malaysian population was as follows: 64.6% Malay,
17.5% Chinese, 15.5% Indians and 2.4% indigenous. Subjects with
BMI>28.0 kg/m2 were excluded from the study.

N (Female%)

Age (years)

BMI (kg/m2)

Adults with lean

1100 (62.5)

59.4 ± 10.7

21.5 ± 1.5

FPG (mmol/l)
5.1 ± 0.8

Adults with obese

820 (66.0)

59.9 ± 10.4

29.1 ± 2.0*

6.0 ± 2.2*

Children without overweight

451 (43.6)

10.1 ± 2.9

16.4 ± 1.5

4.2 ± 1.0

Children with overweight

361 (47.3)

10.1 ± 3.0

21.3 ± 3.8*

4.3 ± 1.0

Non-diabetic controls

1990 (63.5)

60.1 ± 10.3

22.5 ± 2.9

4.4 ± 0.4

Type 2 diabetes

1279 (65.3)

60.2 ± 9.5

25.4 ± 3.7*

8.7 ± 3.3*

Non-diabetic controls

1004 (51.7)

55.6 ± 9.6

25.3 ± 3.6

5.0 ± 0.3

Type 2 diabetes

1049 (47.3)

55.8 ± 10.1

25.3 ± 3.4

9.0 ± 3.1*

Non-diabetic controls

575 (49.6)

45.8 ± 15.1

26.0 ± 5.1

5.6 ± 0.7

Type 2 diabetes

643 (51.7)

56.3 ± 10.4

27.8 ± 5.2

8.6 ± 3.1*

9272 (57.1)

Data are means ± SD. BMI: body mass index. FPG: fasting plasma glucose. *P<0.05 for comparing with controls.
Table 1: Clinical characteristics of subjects.

J Diabetes Metab
ISSN: 2155-6156 JDM, an open access journal

Volume 5 • Issue 9 • 1000437

Citation: Shen C, Sharma M, Reid DC, Li P, Celver J, et al. (2014) A Polymorphic Microdeletion in the RGS9 Gene Suppresses PTB Binding and
Associates with Obesity. J Diabetes Metab 5: 437 doi:10.4172/2155-6156.1000437

Page 3 of 7
Written informed consent was obtained for each subject. Written
informed consent was obtained from the subject or from the parents or
guardians if the subjects were children or minors. The sample and data
collection procedures were approved by the local ethics committees,
respectively. The full names of the respective ethics committee/
institutional review boards are as follows: the Research Ethics Committee
of Nanjing Medical University, Nanjing, China (IRB NMU-1-1-2011),
the Ethics Committee of the Institute of Basic Medical Sciences, Chinese
Academy of Medical Sciences, Beijing, China (PUMC-019-2011),
and the Medical and Research Ethics Committee, Ministry of Health
Malaysia, Kuala Lumpur, Malaysia (IMR-3-3-2007). All these studies
were carried out in accordance with the declaration of Helsinki II.

Genotyping
The ID number of the RGS9 I/D polymorphism in dbSNP
is rs3215227. The position of this RGS9 I/D polymorphism is
represented in Figure 1. To genotype the RGS9 I/D polymorphism
with TaqMan allelic discrimination, a SNP genotyping assay (ID:
AH0I2R) was designed and then synthesized by Life Technologies
(Grand Island, USA). In addition, a specific PCR protocol was
also designed for genotyping the polymorphism. The primers
included RGS9delF1 (5’-aaagaggaaataaatgagtcaa-3’), RGS9delF2
(5’-agttggaagaagaaaagaggaaataaaagaaa-3’)
and
RGS9delR
(5’-agttggaagaagaaaagaggaaattaa-3’). The PCR program was 95˚C,
5min; (95˚C, 30sec; 54˚C, 30se; 72˚C,30 sec) x 31; 72˚C, 8 min. PCR
fragments of sizes 104 bp (deletion allele) and 122 bp (insertion allele)
were detected with 3% w/v agarose gels and gel electrophoresis.

Splicing reporter mini-gene assay
The reporter system and assay used to screen for the possible
actions of PTB binding on the splicing of gene segments containing
the RGS9 I/D polymorphism has been previously described and a
schematic of the minigene construct is shown in this Supplement
section, Figure S1A [18]. The splicing reporter was derived from a
plasmid vector containing a 3 exon minigene under the control of the
human cytomegalovirus promoter that has previously been described

by Wang and colleagues [22]. The small constitutively spliced central
exon of the original splicing reporter contains two restriction cloning
sites, Xho1 and Apa1, into which we inserted a synthesized (Epoch Life
Sciences, Missouri City, TX) fragment of the human RGS9 gene [18].
The inserted RGS9 gene fragment consisted of the final 57 base pairs
of exon 13 (Supplement Figure S1A, grey box,) followed by a fusion
of the first 100 and the last 243 base pairs in the adjacent intron 13
(Supplement Figure S1A, dashed grey bar). The insertion of the regions
from intron 13 of the RGS9 gene effectively splits the central exon
of the original minigene into 2 separate exons thus creating a new
minigene construct with 4 exons (Figure S1A). Two splicing reporters
were constructed, one in which the inserted RGS9 gene fragment was
synthesized with TTTCT insertion (I) and another one in which the
inserted RGS9 gene fragment was synthesized with TTTCT deletion
(D) at the appropriate intron 13 site.
Human embryonic kidney cells (HEK293, American Type Culture
Collection, and Manassas, VA) were separately co-transfected with a
splicing reporter minigene constructs containing either the RGS9
TTTCT I or D allele’s deletion positive and cDNA encoding for either
PTB or nPTB. The transient transfections were performed using
LTX transfection reagent (according to manufacturer’s instructions
Invitrogen, Carlsbad, CA). After 48 hr the cells were harvested and
total cellular RNA was isolated using TRIzol reagent (according to
manufacturer’s instructions, Invitrogen). Next, the RNA was reverse
transcribed (reverse transcriptase enzyme, Sigma Aldrich) at 37˚C for
50 min in a reaction that was primed with random hexamer nucleotides
and contained dNTP mixture and RNase inhibitor (Ambion) and buffer
provided by the enzyme supplier.

Identification of RNA binding proteins by UV-cross linking
All templates for transcription were ordered as custom DNA
oligonucleotides containing T7 promoters from IDT (idtdna.com). An
oligo complimentary to the T7 promoter was also purchased, and the
two were mixed in equimolar ratios, heated to 95˚C and allowed to cool
slowly at room temperature. These mixtures served as transcription
templates for a T7 polymerase reaction using the MEGA short script

Figure 1: rs3215227 encodes a micro deletion in the 3’ splice site (3’ss) region of RGS9 intron 13.
RGS9 gene architecture, annotated with mammalian conservation scores and splicing cis-elements (i.e. branch point, polypyrimidine tract, 3’ splice site (3’ss), shaded
tan) are displayed. The ﬁve nucleotide microdeletion located 72 nucleotides upstream of the 3’ss encompassing a predicted binding site for the splicing repressor
PTB is shaded blue. Additional predicted PTB binding sites are underlined in blue. The regions used to design RNA probes for in vitro binding assay are indicated
below the gene sequences.
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transcription kit (Ambion). Unlabeled cold competitors were prepared
following the protocol supplied with the kit, whereas radiolabeled
probe for UV-crosslinking experiments was prepared with the addition
of 32P UTP to a final concentration of 10 µCi. All samples were purified
using the phenol-chloroform extraction and ethanol precipitation
method and visualized on 7 M urea polyacrylamide gels and quantified
via phosphor imaging (Image Quant; GE Healthcare) and/or UV
spectrometry (Nanodrop).
For each reaction, the radiolabeled probe (wt/R9 RNA and D/R9
RNA in 1, 5 or 10 molar excess for either of the RNA probe) was added
to 30 µg of HeLa cell nuclear extract. Volume was raised to 80 µL with
Buffer E (20 mM Tris pH 7.9, 0.1 M KCl, 0.2 mM EDTA, 20% glycerol,
0.5 mM DTT) and incubated at 25˚C for 30 min. Reactions were
exposed to UV in a UV-crosslinker FB-UVXL-1000 (Fisher Scientific)
for 15 min at 120 mJ/cm2, 5 cm from the UV source. RNA was digested
using RNAse A/T1 mix (Ambion) for 1 hr at 37˚C. For competition
assay, 200 ng (0.01 nM) of radiolabeled probe (S11) were added to 30 µg
of HeLa cell nuclear extract with an increasing amount (0, 5, or 50 fold
molar excess) of unlabeled competitor RNA. The rest of the protocol is
same as described above for UV cross linking experiment. All samples
were then separated by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS PAGE), dried at 80˚C for 25 min, and imaged
using a GE Healthcare storage phosphor screen and scanned on a
Typhoon 9410 variable mode imager and packaged software.

Statistical analyses
The power of the genetic association study (cases and controls)
was calculated with the software of Power and Sample Size Calculation
(Dupont WD, Plummer WD: http://biostat.mc.vanderbilt.edu/ twiki/
bin/view/Main/Power Sample Size). At the 5% significance levels, we
had 82% power to detect OR of 0.8 or 1.25 with a MAF D allele of 0.25
in adult obesity population for generating the association hypothesis of
RGS9 I/D polymorphism and obesity in this study. For the association
analysis of RGS9 I/D polymorphism and T2D, the Jiangsu population
has over 90% power to detect OR of 0.8 or 1.2 with a MAF D allele of
0.28 in control population.
Among controls, genotype frequencies were analyzed by Fisher’s
exact test for Hardy-Weinberg equilibrium (HWE). The allele
frequencies and genotype distributions between cases and controls
were compared by the Chi-square (χ2) test and a P-value of 0.05 was
defined to be statistically significant. Odds Ratios (OR) and 95%
Confidence Intervals (CI) were calculated to test for association. For
the stratification analysis, a multiple unconditional logistic regression
was applied to evaluate the association. The adjustment for covariates
Region/Country
Population

Group

including age and sex was done in the analyses of allelic association
with obesity, while the adjustment for age and BMI was used in the
analyses of the association with T2D in males and females, respectively.
All analyses were performed using IBM SPSS Statistics (Version 20,
SPSS Inc, and Chicago, USA).
In addition, a mata-analysis was used to systematically evaluate
the association of RGS9 I/D polymorphism and T2D for Chinese
Jiangsu population, Beijing population and Malaysia population.
Heterogeneity chi-squared test was used to detect the variation in
estimation attributable to heterogeneity and if I-squared is less 50.0%,
random model would be selected to calculate the pooled OR of the
association between RGS9 I/D polymorphism and T2D. The analyses
were performed using Stata 10.0 (StataCorp LP, College Station, TX).

Results
The RGS9 gene in human consists of 19 exons and the RGS9 I/D
(TTTCT insertion/deletion) polymorphism (rs3215227 in dbSNP) is
located in intron 13. Comparison with other primate species suggests
that the polymorphism arose in the human lineage as a TTTCT deletion
at some point after the human-chimpanzee divergence (Figure 1).
We performed a genetic association study of the RGS9 I/D
polymorphism with obesity and T2D in a larger sample set of Chinese
and Malaysian subjects. The D allele frequency was present at 23.8%
and 28.5%, respectively, in these two Asian populations. The genotype
distributions of the RGS9 I/D polymorphism in the studied populations
were kept in HWE and the results of the study are summarized in Table
2. The genotype distributions of the RGS9 I/D polymorphism in the
studied populations were kept in Hardy-Weinberg equilibrium. In
the Chinese population, women who were obese (BMI ≥ 28) had a
significantly (P=0.003, OR=0.757, 95% CI 0.631-0.909) lower frequency
(23.7 vs 29.0%) of the D allele compared to the women who were lean
(BMI 18.5-23.). The D allele frequency was not different between lean
and obese Chinese men (26.2% vs. 26.6%, P=0.877). In Chinese children,
the D allele was found to be strongly associated with a decreased risk
for obesity in girls (25.5% vs. 36.3%, P=0.002, OR=0.600, 95% CI 0.4360.828) and moderately associated with a decreased risk for obesity in
boys (24.3% vs. 30.5%, P=0.039, OR=0.730, 95% CI 0.541-0.984).
Further stratification analyses for the association of the RGS9 I/D
polymorphism with obesity were performed separately in women and
men and also adjusted for covariates including age, BMI, daily diet and
levels of physical activities. Results of the study are summarized in Table
3. In the Chinese population, women who were obese had a significantly
(23.7 vs 29.0%, P=0.003, OR=0.753, 95% CI 0.625-0.906) lower frequency
Genotype

I/I

I/D

D/D

Allele D
Frequency

P-value
OR (95% CI) a
0.019a
0.838 (0.723-0.972) a

Jiangsu/China
Chinese

Adults, lean BMI 18.5-23.9

566

452

82

0.28

Adults, obese BMI ≥ 28

463

310

47

0.25

Jiangsu/China
Chinese

Children BMI p20-50

204

194

53

0.33

Children BMI p>80

202

139

20

0.25

Jiangsu/China
Chinese

Non-diabetic

1035

814

141

0.28

T2DM

678

509

92

0.27

Beijing/China
Chinese

Non-diabetic

537

372

95

0.28

T2DM

555

397

97

0.28

Penisular/Malaysia
Malaysian

Non-diabetic

331

241

57

0.28

T2DM

295

239

50

0.29

3.1×10-4 a
0.667 (0.535-0.831) a
0.820b
1.014 (0.870-1.147) b
0.999b
1.000 (0.876-1.141) b
0.741b
0.966 (0.785-1.188) b

Tests were done with an additive model; BMI: Body Mass Index; T2DM: Type 2 Diabetes; a: Adjustment for Age and Sex; b: Adjustment for Age, Sex and BMI.
Table 2: The allele D frequency of the RGS9 I/D polymorphism and its association with obesity.
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Region/Country
Population

Gender

Group

Jiangsu/China
Chinese

Women

Jiangsu/China
Chinese

Genotype
I/I

I/D

D/D

Allele D
Frequency

P-value
OR (95% CI)

Adults, lean BMI 18.5-23.9
Adults, obese BMI ≥ 28

342
316

291
194

54
31

0.290
0.237

0.003a
0.753 (0.625-0.906) a

Men

Adults, lean BMI 18.5-23.9
Adults, obese BMI ≥ 28

224
147

162
116

27
16

0.262
0.265

0.965a
1.006 (0.782-1.293) a

Jiangsu/China
Chinese

Girls

Children BMI p20-50
Children BMI p>80

91
85

92
64

32
8

0.363
0.255

0.002a
0.604 (0.437-0.835) a

Jiangsu/China
Chinese

Boys

Children BMI p20-50
Children BMI p>80

113
117

102
75

21
12

0.305
0.243

0.038a
0.724 (0.533-0.983)a

Jiangsu/China
Chinese

Women

Non-diabetic BMI<28
T2DM BMI<28

656
450

511
325

97
60

0.286
0.266

0.669b
0.967 (831-1.126)b

Jiangsu/China
Chinese

Men

Non-diabetic BMI<28
T2DM BMI<28

379
228

303
184

44
32

0.269
0.279

0.317b
1.113 (0.902-1.372)b

Beijing/China
Chinese

Women

Non-diabetic BMI<28
T2DM BMI<28

281
263

193
197

46
36

0.274
0.271

0.815b
0.977 (0.805-1.186)b

Beijing/China
Chinese

Men

Non-diabetic BMI<28
T2DM BMI<28

256
292

179
200

49
61

0.286
0.291

0.833b
1.020 (0.850-1.223)b

Penisular Malaysia
Women
Malaysian

Non-diabetic BMI<28
T2DM BMI<28

142
158

102
126

24
27

0.280
0.289

0.168b
0.809 (0.599-1.094)b

Penisular Malaysia
Men
Malaysian

Non-diabetic BMI<28
T2DM BMI<28

158
172

120
133

29
27

0.290
0.282

0.395b
1.135 (0.848-1.517)b

Tests were done with an additive model; BMI: Body Mass Index; T2D: Type 2 Diabetes; a: Adjustment for Age; b: Adjustment for Age and BMI
Table 3: Stratification analysis on the association of RGS9 I/D polymorphism with obesity.

of the D allele compared to the women who were lean (23.7 vs. 29.0%,
P=0.003, OR=0.753, 95% CI 0.625-0.906). The D allele frequency was
not different between lean and obese Chinese men (26.2% vs. 26.6%,
P=0.965, OR=1.006, 95% CI 0.782-1.293). In Chinese children, the D
allele was found to be strongly associated with a decreased risk for obesity
in girls (25.5% vs. 36.3%, P=0.002, OR=0.604, 95% CI 0.437-0.835) and
moderately associated with a decreased risk for obesity in boys (24.3% vs.
30.5%, P=0.038, OR=0.724, 95% CI 0.53-0.983).
In order to ask if there was any association between the RGS9 I/D
polymorphism and T2D, we selected two cohorts of Chinese (from
Jiangsu province and Beijing, respectively) and one cohort of Malaysian
adults with and without T2D for analyses and those patients were not
obese. We found no significant difference in the D allele frequency
between non-diabetic controls and T2D patients in either the Chinese
or Malaysian populations (Table 2) although the analyses were
stratified by gender (Table 3). In addition, a mata-analysis was used to
systematically evaluate the association of RGS9 I/D polymorphism and
T2D for Chinese Jiangsu population, Beijing population and Malaysia
population. Heterogeneity test indicated that there is no heterogeneity
among the study populations (χ2=0.15, P=0.930) and I2 was 0.0%,
random model was selected to calculate the association and pooled OR
(95%CI) was 1.000 (0.917-1.090) for the association between RGS9 I/D
polymorphism and T2D (z=0.00, P=0.997).
Since the RGS9 I/D polymorphism was strongly associated
with obesity and matched the consensus binding motif for the RNA
binding Polypyrimidine Tract Binding Protein (PTB) [23], we tested
if the polymorphism could modulate RGS9 gene function through a
mechanism of allele specific interactions with PTB. In our previous
study, we had shown that processing of the RGS9 gene transcript
was altered by the I/D polymorphism, but we did not report on the
binding of PTB to the RNA alleles or the effect of PTB expression
transcriptional processing of these RNA alleles. Exons 13 and 14, which
flank the polymorphism, code for the conserved and functionally
important RGS domain. Therefore, alterations in splicing, such as exon
skipping, at this site, produced as a result of reduced PTB binding to the
D allele, will lead to alterations in the levels of functional RGS9 protein.
Altered PTB binding could also result in allele specific changes in RNA
polyadenylation, stability or structure [23].
J Diabetes Metab
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We assayed the RGS9 I/D RNA alleles for differences in binding
to PTB in cell nuclear extracts. The binding affinity of PTB to these
allelic RNA substrates was determined using a standard Ultraviolet
(UV) cross-linking reaction. Briefly, this assay captures RNA-protein
binding events through a label transfer strategy. RNA corresponding
to the 2 alleles is transcribed utilizing 32P-radio-labeled nucleotides
and incubated with a nuclear extract from cells to allow RNA-protein
complexes to form. The internally radio-labeled RNA is covalently
cross-linked to bound protein using UV light. RNAses are used to “trim”
the RNA that is covalently attached to protein to a few nucleotides and
the trimmed RNA effectively serves as a radiolabel for the interacting
proteins. The mobility of these labeled RNA-binding proteins can be
measured by Poly-Acrylamide Gel Electrophoresis (PAGE) and their
identity confirmed by immunoprecipitation.
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Figure 2: PTB binds the RGS9 TTTCT insertion (I) allele with 10-fold higher
afﬁnity than the deletion (D) allele.
RNA oligos corresponding to the I and D alleles and the previously
characterized PTB ligand, S11, were radiolabelled, incubated in HeLa extract
and UV crosslinked to interacting proteins. Radiolabeled crosslinked proteins
were visualized by SDS-PAGE/autoradiography. A. A prominent 58 kD band
corresponding to the molecular weight of PTB can be detected on both the I
and D allelic probes. B. The 58 kD band is also detected with the S11 ligand
(lane 1) and can be immunoprecipitated with antibodies against PTB (lane 2).
The relative strength of the I or D RNA allele to bind PTB is inferred from the
ability of unlabeled RNA probes (cold comp), corresponding to these alleles, to
compete with the radiolabeled S11 ligand for PTB binding (lanes 3-9).
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Both the I and D RNA alleles bound a 58 kD protein, that
corresponded to the molecular weight of PTB, with the I RNA allele
appearing to bind more strongly (Figure 2A). The same 58 kD protein
was also detected using a previously characterized RNA ligand for PTB,
S11 (Figure 2B, left panel) [5]. Crosslinking of radiolabeled S11 with cell
nuclear extracts followed by immunoprecipitation of PTB confirmed
that PTB is the dominant 58 kD binding protein for S11 (Figure 2B,
right panel, lanes 4 and 7). The crosslinking efficiency and degree of
radiolabel incorporation can vary from one RNA substrate to another
so that relative signals obtained for the 58 kD protein in Figure 2A do
not necessarily represent the relative level of binding of the I and D RNA
alleles to that protein. Therefore, a more accurate representation of the
level of binding of the RNA alleles to PTB was achieved by examining
the ability of each of the unlabeled alleles to compete with the binding
of PTB to the previously characterized radiolabeled RNA ligand for
PTB, S11 [14]. We performed competition binding experiments to
PTB with radiolabeled S11 and progressively higher concentrations
(5-50 molar excess) of unlabeled I and D variants of the RGS9 RNA,
respectively (Figure 2B, lanes 3-9). The relative strength of the I or D
RNA allele to bind PTB was inferred from the ability of unlabeled RNA
probes, corresponding to these alleles, to compete with the radiolabeled
S11 ligand for PTB binding. The results show that a 10-fold higher
concentration of the D variant is required to achieve the same amount
of competition with S11 at PTB as the I allele (Figure 2B, right panel,
lanes 3-9) and indicate that the I RNA allele does indeed bind PTB with
much higher affinity than the D variant.
We then utilized a splicing reporter assay to examine whether the
difference in interaction between PTB and the two RNA alleles could
alter how the alleles were functionally processed in cells. Since RGS9

transcripts are primarily expressed either in the brain or the retina we
also tested the effects of a neuronal paralog of PTB, nPTB. Supplemental
Figure S1A represents a schematic of the RGS9 mini-gene construct
composed of four exons with the I/D polymorphism-containing
sequence from intron 13 of RGS9 inserted between experimental exons
2 and 3 which was transfected into cells.
RNA isolated post-transfection was analyzed by reversetranscriptase (RT)-PCR. Correct constitutive splicing of all 4 exons
corresponded to a 451 nucleotide (nt) product (“a” in Figure 3A and
Supplemental Figure S1B). Coexpression of PTB or nPTB led to the
repression of correct splicing and the detection of two additional
PCR products corresponding to distinct alternatively spliced mRNA
products. The splicing of experimental exons 1 and 2, but skipping of
the exon immediately downstream of the polymorphism, exon 3, leads
to splicing of exon 2 and 4 and results in an ~400 nt band (“b” band).
Splicing of exon 1 and 4 due to skipping of exons 2 and 3 was also
detected (“c” band).
The repression of splicing produced by co-expression of either PTB
or nPTB was biased to the RGS9 TTTCT I allele (Figure 3) and the
fraction of transcript that included all 4 exons (“a” band) produced
with the I variant was significantly less than with the D variant, i.e. the
repressive effect of PTB or nPTB was significantly stronger on the I
allele. We confirmed preferential PTB binding to the I allele in vivo by
repeating the UV crosslinking in cell culture and coimmunoprecipitating
the crosslinked PTB/pre-mRNA complexes (Supplemental Figure S2).
The latter confirmed that the I allele binds more strongly to PTB in
vivo and thus has a greater potential to be modulated by PTB than the
D allele.

Discussion
Here, we have present genetic and biochemical data to support a
role for the RGS9 TTTCT I/D polymorphism in affecting obesity in
humans. These findings appear to parallel those us previously observed
in rodents where RGS9 expression levels are correlated with adiposity/
body weight [18].
Men and women differ in body composition, patterns of weight gain,
hormone biology, metabolic markers and the manner in which social,
ethnic and environmental factors contribute to the obesity phenotype
[24-26]. In this context, our observation of a sexually dimorphic
association of a polymorphism in the RGS9 gene is significant as it is
one of few studies that have demonstrated sex-specific effects of weightinfluencing gene variants. Our previous mouse studies had produced
similar results: targeted disruption of the rgs9 gene resulted in a more
pronounced increase in body weight in female mice and the divergence
in body weight between the knockout mice and wild-type mice occurred
at an earlier age in females [18]. The mechanisms underlying the sexspecific effects of obesity and eating behavior are not well understood
and this study establishes RGS9 as one starting point to study some of
these mechanisms.
Figure 3: Alternative splicing of a minigene reporter construct containing the
RGS9 TTTCT I/D alleles.
A. The RGS9 I and D allele fragment-containing minigenes were separately
co-transfected into cells with or without either PTB (left panel) or nPTB (right
panel). The minigene transcripts were visualized by reverse transcription,
PCR amplification and agarose gel electrophoresis. The bands “a”, “b”,
and “c” represent alternatively spliced products of the minigene reporter. B.
Densitometric quantification of the relative intensity of band “a”, i.e. full-length
alternatively spliced product, expressed as percentage of the total intensity
from “a”, “b”, and “c” with and without co-expression of PTB (left panel) or nPTB
(right panel) (*p<0.01, t test).
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Human genetic studies have linked variations in two other R7
RGS proteins, RGS6 and RGS7 to obesity [27]. These studies provide a
precedent for R7 RGS family proteins regulating body-weight through
their expression in the brain since the protein products of the R7
RGS gene family have been reliably detected only in the brain or in
excitable tissue such as retina and heart [5,9]. Further support for a role
for R7 RGS proteins in regulating body weight and adiposity has been
provided through studies with Gβ5, a unique G protein β subunit. It
has been reported that mice with a targeted deletion of one copy of
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Gβ5, are heavier and have increased adiposity when compared to their
wild-type counterparts [28]. Gβ5 protects R7 RGS family proteins from
proteolysis and expression of R7 RGS family proteins, including RGS9,
is eliminated or hugely reduced in the absence of Gβ5 [5,29].
According to the information from dbSNP database and our
recent study with a smaller set of Asian subjects [25], the RGS9 I/D
polymorphism is also common in Japanese and Koreans, which
suggests that the polymorphism may have utility in biomarker panels
for predicting obesity in Asian populations. It was more practicable to
investigate the association in this population versus in Caucasians in
whom the occurrence of the D allele is quite rare. In fact, our previous
results with rodents indicate that RGS9 contributes to body weight
set-points in multiple species and therefore is likely to contribute
to regulating body-weight in humans regardless of ethnicity [25].
Furthermore, most of T2D patients included in this study were not
obese. Inclusion of T2D patients with lean for the study may allow
ascertaining whether the RGS9 I/D polymorphism are associated with
T2D or not.
In conclusion, we present genetic and biochemical data to support
a genetic role of RGS9 in obesity but unlikely in T2D. The RGS9 I/D
polymorphism influences the post-transcriptional processing of the
gene through an altered affinity for the splicing factor PTB and are
associated with obesity.
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